BENGALURU, Indien, 25. Juni 2024 /PRNewswire/ — Biocon Biologics Ltd (BBL), ein globales, voll integriertes Biosimilars-Unternehmen und eine Tochtergesellschaft von Biocon Ltd (BSE-Code: 532523, NSE: BIOCON) hat von der Europäischen Arzneimittelbehörde (EMA) die Genehmigung erhalten, in…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.